English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sjögren ́s syndrome (SS) is an autoimmune disease characterized by a lymphocytic infiltration of the salivary and lacrimal glands, leading to a progressive destruction of these glands, and is frequently accompanied by systemic symptoms (1). Non-Hodgkin lymphoma (NHL) represents a major complication in the evolution of SS patients (2). We describe a case of retroperitoneal diffuse large B-cell lymphoma (DLBCL) occurring in a geriatric patient with an underlying SS of 8 years of evolution. A non-smoking 76-year-old female patient was diagnosed with SS in 2003 based on the American-European Consensus Group Criteria for Sjögren ́s syndrome (3) (xerostomia, xerophthalmia, a positive Schirmer test (<5 mm), pathological salivary gland scintigraphy, positive antinuclear antibodies (ANA titer count 1:1280), positive rheumatoid factor (RF) 56 UI/mL (N=0-14), and positive anti-RO/SS-A and anti-La/SS-B). The patient had been under treatment with oral hydroxychloroquine and subcutaneous methotrexate for non-erosive polyarthritis since 2008. She was admitted to our hospital in May 2012 because of asthenia, intermittent fever, and 20 kg weight loss of 6 months of evolution. The physical examination demonstrated cachexia without palpable peripheral lymphadenopathy. Blood test has highlighted: erythrocyte sedimentation rate (ESR) 118 mm (N=3-12), leukocytes 3500/mm3 (N=4000-12,900) (neutrophils 2560/mm3), hemoglobin 10 g/dL (N=12-15), hematocrit 30% (N=37-47), hypergammaglobulinemia 23% (N=11.8-18.8), beta 2 microglobulin 7.2 mg/L (N=0.7-1.8), and circulating cryoglobulins were positive. Other tumoral markers were all negative. Serological tests of human immunodeficiency virus, hepatitis B, hepatitis C, Epstein-Barr virus, and cytomegalovirus were also negative. Computed tomography was done (Figure 1) and has shown a retroperitoneal paraaortic mass of 52x35x61 mm at the level of the left renal hilum with intratumoral central necrosis. A CT-guided needle biopsy of the retroperitoneal mass was obtained under local anesthesia. A histopathological diagnosis of DLBCL was confirmed according to the newly proposed revised European–American classification of lymphoid neoplasms (4). Methotrexate was suspended, and the patient was treated every 3 weeks for 8 cycles of R-CHOP scheme (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone). Complete remission was achieved (no B symptoms) that was corroborated by CT 4 weeks after completion of the eighth course of R-CHOP and at the sixth month thereafter. SS is a chronic autoimmune disease that is at the crossroads of systemic autoimmunity and malignancy (2, 5). B-cell NHL represents the most serious complication in the evolution of SS patients (2, 5). The risk was estimated to be 44 times greater than that observed in a comparable normal population (6.4 cases per 1000 per year in 136 women with SS observed for an average of 8.1 years) (5). The majority of SS-associated NHL is preferentially low-grade and extranodal in salivary glands and in other mucosa-associated lymphoid tissues (MALT) (5). Moreover, high-grade transformation to DLBCL has been occasionally and uncommonly found in SS patients (5). In a systematic review by Váróczy L et al. (6) to assess the rate of associated malignant lymphomas to autoimmune diseases, of 421 NHL patients, 32 (7.6%) had an autoimmune disease (26 females, mean age 48.3 years). The most common diagnosis was Sjögren ́s syndrome, with 11 cases (100% females). The evolution from benign lymphocytic infiltration characteristic of SS to malignant NHL is probably a multistep process, the underlying molecular events of which are still unknown (2, 5, 6). In searching for SS-associated NHL, several considerations have to be taken into account in our case: first, the presence of various autoantibodies, such as the RF and anti-SSA/ SSB antibodies, as well as hypergammaglobulinemia and positive circulating cryoglobulins, reflects B-cell hyperactivity (5); second, causality between methotrexate and DLBCL is often difficult to prove, but it is likely that this drug might have a role in the development (6). In several studies, the combination of R-CHOP has a good safety-efficacy profile, inducing responses and long-term survival in over 90% of patients with Rami Qanneta Letter to the Editor

european journal of rheumatology :/european journal of rheumatology

Sjögren´s syndrome complicated with retroperitoneal Non-Hodgkin´s lymphoma: A case of an elderly woman during methotrexate treatment, treated with R-CHOP